• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Herpes Zoster Market

    ID: MRFR/HC/16521-CR
    100 Pages
    Garvit Vyas
    December 2023

    US Herpes Zoster Market

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Herpes Zoster Market Infographic
    Purchase Options

    US Herpes Zoster Market Summary

    The US Herpes Zoster market is projected to grow from 3500 USD Million in 2024 to 5200 USD Million by 2035.

    Key Market Trends & Highlights

    US Herpes Zoster Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 3.66 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 5200 USD Million, indicating robust growth opportunities.
    • In 2024, the market is valued at 3500 USD Million, reflecting a solid foundation for future expansion.
    • Growing adoption of vaccination programs due to increasing awareness of Herpes Zoster is a major market driver.

    Market Size & Forecast

    2024 Market Size 3500 (USD Million)
    2035 Market Size 5200 (USD Million)
    CAGR (2025 - 2035) 3.66%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Key Companies in the US Herpes Zoster Market market include

    FAQs

    What is the expected market size of the US Herpes Zoster Market in 2024?

    The US Herpes Zoster Market is expected to be valued at 42.12 million USD in 2024.

    What is the projected market size of the US Herpes Zoster Market by 2035?

    By 2035, the US Herpes Zoster Market is projected to reach a value of 90.42 million USD.

    What is the compound annual growth rate (CAGR) for the US Herpes Zoster Market from 2025 to 2035?

    The expected CAGR for the US Herpes Zoster Market from 2025 to 2035 is 7.192 percent.

    Which are the prominent players in the US Herpes Zoster Market?

    Key players in the US Herpes Zoster Market include Novartis, AstraZeneca, Merck, and Eli Lilly among others.

    What is the market size for Laboratory Testing in the US Herpes Zoster Market in 2024?

    In 2024, the market size for Laboratory Testing in the US Herpes Zoster Market is valued at 10.5 million USD.

    How much is the market for Serological Testing expected to grow by 2035?

    The market for Serological Testing is expected to grow to 20.0 million USD by 2035.

    What is the estimated market value for Real-Time Polymerase Chain Reaction (PCR) in 2024?

    The estimated market value for Real-Time Polymerase Chain Reaction (PCR) in 2024 is 8.0 million USD.

    What growth rate can be expected for the market during the forecast period?

    The market is anticipated to show a growth rate of 7.192 percent during the forecast period from 2025 to 2035.

    How is the market for Immunofluorescent Microscopy expected to change by 2035?

    The market for Immunofluorescent Microscopy is expected to increase to 10.5 million USD by 2035.

    What is the projected value of the Others diagnosis segment in 2024?

    The Others diagnosis segment is projected to be valued at 8.02 million USD in 2024.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials